Literature DB >> 23567472

Assessment of risk factors for post-rewarming "rebound hyperthermia" in cardiac arrest patients undergoing therapeutic hypothermia.

S A Winters1, K H Wolf, S A Kettinger, E K Seif, J S Jones, T Bacon-Baguley.   

Abstract

INTRODUCTION: The outcomes associated with therapeutic hypothermia (TH) after cardiac arrest, while overwhelmingly positive, may be associated with adverse events. The incidence of post-rewarming rebound hyperthermia (RH) has been relatively unstudied and may worsen survival and neurologic outcome. The purpose of this study was to determine the incidence and risk factors associated with RH as well as its relationship to mortality, neurologic morbidity, and hospital length of stay (LOS).
METHODS: A retrospective, observational study was performed of adult patients who underwent therapeutic hypothermia after an out-of-hospital cardiac arrest. Data describing 17 potential risk factors for RH were collected. The primary outcome was the incidence of RH while the secondary outcomes were mortality, discharge neurologic status, and LOS.
RESULTS: 141 patients were included. All 17 risk factors for RH were analyzed and no potential risk factors were found to be significant at a univariate level. 40.4% of patients without RH experienced any cause of death during the initial hospitalization compared to 64.3% patients who experienced RH (OR: 2.66; 95% CI: 1.26-5.61; p=0.011). The presence of RH is not associated with an increase in LOS (10.67 days vs. 9.45 days; absolute risk increase=-1.21 days, 95% CI: -1.84 to 4.27; p=0.434). RH is associated with increased neurologic morbidity (p=0.011).
CONCLUSIONS: While no potential risk factors for RH were identified, RH is a marker for increased mortality and worsened neurologic morbidity in cardiac arrest patients who have underwent TH.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Length of stay; Mortality; Neurologic morbidity; Rebound hyperthermia; Therapeutic hypothermia

Mesh:

Year:  2013        PMID: 23567472     DOI: 10.1016/j.resuscitation.2013.03.027

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  9 in total

Review 1.  Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

2.  [Recommendation on temperature management after cardiopulmonary arrest and severe traumatic brain injury in childhood beyond the neonatal period : Statement of the German Society for Neonatology and Pediatric Intensive Care Medicine (GNPI) and the scientific Working Group for Paediatric Anaesthesia (WAKKA) of the German Society of Anaesthesiology and Intensive Care (DGAI)].

Authors:  S Brenner; C Eich; G Rellensmann; M U Schuhmann; T Nicolai; F Hoffmann
Journal:  Anaesthesist       Date:  2017-02       Impact factor: 1.041

3.  Delayed Fever and Neurological Outcome after Cardiac Arrest: A Retrospective Clinical Study.

Authors:  Edoardo Picetti; Marta Velia Antonini; Yerma Bartolini; Antonino DeAngelis; Laura Delaj; Irene Florindo; Fabio Villani; Maria Luisa Caspani
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

Review 4.  Beyond return of spontaneous circulation: update on post-cardiac arrest management in the intensive care unit.

Authors:  Yew Woon Chia; Shir Lynn Lim; Julian Kenrick Loh; Benjamin Sieu-Hon Leong; Marcus Eng Hock Ong
Journal:  Singapore Med J       Date:  2021-08       Impact factor: 1.858

5.  Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial.

Authors:  Jean Baptiste Lascarrou; Ferhat Meziani; Amélie Le Gouge; Thierry Boulain; Jérôme Bousser; Guillaume Belliard; Pierre Asfar; Jean Pierre Frat; Pierre François Dequin; Jean Paul Gouello; Arnaud Delahaye; Ali Ait Hssain; Jean Charles Chakarian; Nicolas Pichon; Arnaud Desachy; Fréderic Bellec; Didier Thevenin; Jean Pierre Quenot; Michel Sirodot; François Labadie; Gaétan Plantefeve; Dominique Vivier; Patrick Girardie; Bruno Giraudeau; Jean Reignier
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-03-07       Impact factor: 2.953

6.  Adverse events associated with poor neurological outcome during targeted temperature management and advanced critical care after out-of-hospital cardiac arrest.

Authors:  Young-Min Kim; Chun Song Youn; Soo Hyun Kim; Byung Kook Lee; In Soo Cho; Gyu Chong Cho; Kyung Woon Jeung; Sang Hoon Oh; Seung Pill Choi; Jong Hwan Shin; Kyoung-Chul Cha; Joo Suk Oh; Hyeon Woo Yim; Kyu Nam Park
Journal:  Crit Care       Date:  2015-07-22       Impact factor: 9.097

Review 7.  Targeted Temperature Management; Review of Literature and Guidelines; A Cardiologist's Perspective.

Authors:  Taimoor Hashim; Ranjith Shetty
Journal:  Curr Cardiol Rev       Date:  2018

8.  Factors Associated With Rebound Hyperthermia After Targeted Temperature Management in Out-of-Hospital Cardiac Arrest Patients: An Explorative Substudy of the Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors Trial.

Authors:  Aki Holm; Hans Kirkegaard; Fabio Silvio Taccone; Eldar Søreide; Anders M Grejs; Valdo Toome; Christian Hassager; Bodil S Rasmussen; Timo Laitio; Christian Storm; Johanna Hästbacka; Markus B Skrifvars
Journal:  Crit Care Explor       Date:  2021-07-06

9.  Early Post-Rewarming Fever Is Associated with Favorable 6-Month Neurologic Outcomes in Patients with Out-Of-Hospital Cardiac Arrest: A Multicenter Registry Study.

Authors:  Hyoung Youn Lee; Dong Hun Lee; Byung Kook Lee; Kyung Woon Jeung; Yong Hun Jung; Seung Phil Choi; Jung Soo Park; Jae Hoon Lee; Kap Su Han; Yong Il Min
Journal:  J Clin Med       Date:  2020-09-10       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.